Takeda Loses First Federal Trial Over Actos Diabetes Drug - Bloomberg

Sales Peak Actos sales peaked in the year ended March 2011 at $4.5 billion and accounted for 27 percent of Takedas revenue at the time, according to data compiled by Bloomberg. Read the story here http://www.bloomberg.com/news/2014-04-07/takeda-loses-first-federal-trial-over-actos-diabetes-drug.html